Today, we’ve already moved a step ahead of COVID-19. After Pfizer got FDA approval for children above 12 a couple of weeks ago, the same issues lay upon Moderna. As they intend to spread it wider, it’s absolutely necessary for the Moderna COVID-19 vaccine to be safe for children.
According to results, that the company announced, the vaccine proves it is highly effective in teens aged 12 – 17. Being the second COVID-19 vaccine for that has the impact of increasing the supply and choices younger people make. Both options are messenger RNA (mRNa) vaccines, so they contain the genetic code (mRNA) of the SARS-CoV-2 spike protein. When they enter human bodies, they teach the cells how to recognize it, and produce antibodies, to protect us.
It’s really amazing half of them received the Moderna COVID-19 vaccine and the others received a placebo. 4 of the placebo participants got COVID-19 2 weeks after the second dose, but from the rest, there was 0. So, it’s absolutely safe for our children.
Regarding mild COVID-19 cases, the numbers go up to 93% after getting the first jab concerning any infection. Mild to moderate side effects are headache, fatigue, muscle aches, and chills, expressed after the second dose.
Despite waiting for CDC approval in June, the government is currently investigating cases of heart inflammation in young adults. In detail, it includes children, received both shots of either of the mRNA COVID-19 vaccines. In a 17 May meeting, scientists presented reports of myocarditis to the Advisory Committee on Immunization Practices (ACIP). More men suffer from this condition, than women, within 4 days after the second dose. What happens is, that it causes inflammation which affects the heart muscle’s electrical system and reduces the ability to pump blood.
There were several cases of myocarditis, linked with the MIS-C, also post COVID-19. However, there is a possibility that the few cases reported by the vaccine safety group could not be related to the vaccine. The doctors observed symptoms, such as fever, fainting, breathing difficulties, rapid breathing, and rapid or abnormal heart rhythms. In fact, a whole host of viruses could cause such a problem, but it’s a rare condition among children.
MVS Pharma GmbH is an innovative pharmaceutical start-up company, which researches in the area of reducing viruses and bacteria with plant based aerosols. Their special formula ensures the purity and stability of the used ingredients during storage.
Liliya Ganeva is an article writer, who explores all the actual, up-to-date COVID-19 information, and the possibilities for producing aerosols made out of plants against respiratory viruses and bacteria.